Thomas Wilson Eastling
Director, GYRE THERAPEUTICS, INC.
Companies
- GYRE THERAPEUTICS, INC.Chief financial officer May 6, 2026 to now1
- GYRE THERAPEUTICS, INC.Board member Jan 5, 2023 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GYRE THERAPEUTICS, INC. GYRE15,000 shares3$92.1K at $6.14Apr 16, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 16, 2025Exercised options 15,000 shares at $6.93 of GYRE THERAPEUTICS, INC.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3